10 Nov 2025
We are deeply saddened by the passing of Professor Michel Dumas on November 8, 2025, in Limoges, France.
5 Nov 2025
4 Nov 2025
This issue provides the results of the election at October's Council of Delegates, which was held at the World Congress of Neurology (WCN) in Seoul, South Korea.
24 Oct 2025
The PNS Laura Feltri Training Grants Program offers funding to junior investigators to develop a 2-year project under a PNS Member mentor. New in 2026, PNS will offer up to three 2-year training grants.
14 Oct 2025
At the World Congress of Neurology, Prof. Sir John Hardy (UCL, London) highlighted how decades of genetic and molecular research are driving real progress in Alzheimer’s care, with advances in amyloid therapies, microglial biology, and biomarkers paving the way for more precise diagnosis and treatment.
14 Oct 2025
At the World Congress of Neurology, Prof. Sean Pittock (Mayo Clinic, USA) outlined new approaches that could accelerate lasting remission in rare autoimmune neurological diseases, including targeted CAR-T therapies, immune “reset” treatments, and innovative trial designs — marking a shift toward restoring immune balance and long-term recovery.
14 Oct 2025
At the World Congress of Neurology, Dr. Mikołaj Ogrodnik revealed that senescent cells also accumulate in the brain, driving neurodegeneration and cognitive decline. He highlighted emerging senolytic therapies and advances in targeting cellular aging, pointing to new possibilities for reversing age-related brain dysfunction.
14 Oct 2025
At the World Congress of Neurology, Dr. Fumihiko Sakai (Japan) showcased the Fujitsu-GPAC initiative — a large-scale workplace migraine program reaching over 80,000 employees — demonstrating how education and virtual care can reduce stigma, enhance self-management, and boost productivity, offering a global model for improving brain health at work.
14 Oct 2025
At WCN, Prof. Charlotte Cordonnier urged neurologists to apply lessons from the ischemic stroke revolution to intracerebral hemorrhage (ICH) care and research. 2025